Gohachiro Miyamoto

586 total citations
35 papers, 485 citations indexed

About

Gohachiro Miyamoto is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, Gohachiro Miyamoto has authored 35 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 15 papers in Oncology and 13 papers in Pharmacology. Recurrent topics in Gohachiro Miyamoto's work include Drug Transport and Resistance Mechanisms (14 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Gohachiro Miyamoto is often cited by papers focused on Drug Transport and Resistance Mechanisms (14 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Gohachiro Miyamoto collaborates with scholars based in Japan, Spain and Canada. Gohachiro Miyamoto's co-authors include Nasir Zahid, Jack Uetrecht, Yoshihiko Shimokawa, Ken Umehara, Hitoshi Akiyama, Hiroyuki Sasabe, Shoji Kudo, Eiji Kashiyama, Toshihisa Koga and Masaaki Odomi and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Chemical Research in Toxicology and Drug Metabolism and Disposition.

In The Last Decade

Gohachiro Miyamoto

35 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gohachiro Miyamoto Japan 12 140 128 122 81 61 35 485
J.‐M. POIRIER France 16 140 1.0× 119 0.9× 74 0.6× 143 1.8× 52 0.9× 38 697
Joan Moncrieff South Africa 13 116 0.8× 137 1.1× 72 0.6× 78 1.0× 52 0.9× 39 467
Leon Shargel United States 14 135 1.0× 99 0.8× 71 0.6× 89 1.1× 78 1.3× 40 609
W. Roth Germany 10 102 0.7× 227 1.8× 73 0.6× 114 1.4× 30 0.5× 18 647
V.G. Casabó Spain 17 88 0.6× 134 1.0× 195 1.6× 168 2.1× 74 1.2× 39 689
Rebecca L. Oberle United States 7 86 0.6× 81 0.6× 137 1.1× 68 0.8× 41 0.7× 9 472
Barbara W. LeDuc United States 13 132 0.9× 100 0.8× 57 0.5× 106 1.3× 54 0.9× 28 455
Michael A. Zemaitis United States 18 260 1.9× 117 0.9× 135 1.1× 178 2.2× 91 1.5× 44 813
DB Jack United Kingdom 15 152 1.1× 153 1.2× 82 0.7× 70 0.9× 96 1.6× 40 609
D. Tang–Liu United States 12 178 1.3× 182 1.4× 85 0.7× 160 2.0× 82 1.3× 22 701

Countries citing papers authored by Gohachiro Miyamoto

Since Specialization
Citations

This map shows the geographic impact of Gohachiro Miyamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gohachiro Miyamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gohachiro Miyamoto more than expected).

Fields of papers citing papers by Gohachiro Miyamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gohachiro Miyamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gohachiro Miyamoto. The network helps show where Gohachiro Miyamoto may publish in the future.

Co-authorship network of co-authors of Gohachiro Miyamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Gohachiro Miyamoto. A scholar is included among the top collaborators of Gohachiro Miyamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gohachiro Miyamoto. Gohachiro Miyamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimokawa, Yoshihiko, Hitoshi Akiyama, Eiji Kashiyama, Toshihisa Koga, & Gohachiro Miyamoto. (2005). High performance liquid chromatographic methods for the determination of aripiprazole with ultraviolet detection in rat plasma and brain: Application to the pharmacokinetic study. Journal of Chromatography B. 821(1). 8–14. 67 indexed citations
2.
Sasabe, Hiroyuki, et al.. (2005). Carrier-Mediated Uptake of Grepafloxacin, a Fluoroquinolone Antibiotic, by the Isolated Rat Lung Cells. Drug Metabolism and Pharmacokinetics. 20(6). 491–495. 6 indexed citations
3.
4.
Sasabe, Hiroyuki, et al.. (2004). Differential Involvement of Multidrug Resistance-Associated Protein 1 and P-Glycoprotein in Tissue Distribution and Excretion of Grepafloxacin in Mice. Journal of Pharmacology and Experimental Therapeutics. 310(2). 648–655. 44 indexed citations
5.
Miyamoto, Gohachiro, et al.. (2002). The Effects of Concomitant Administration of Theophylline and Toborinone on the Pharmacokinetics of Both Compounds in Poor and Extensive Metabolizers via CYP2D6. The Journal of Clinical Pharmacology. 42(5). 492–500. 1 indexed citations
6.
Miyamoto, Gohachiro, et al.. (2002). The Pharmacokinetics of Toborinone in Subjects with Congestive Heart Failure and Concomitant Renal Impairment and/or Concomitant Hepatic Impairment. The Journal of Clinical Pharmacology. 42(12). 1318–1325. 3 indexed citations
7.
Koyama, Noriyuki, Hisahiro Sasabe, & Gohachiro Miyamoto. (2002). Involvement of cytochrome P450 in the metabolism of rebamipide by the human liver. Xenobiotica. 32(7). 573–586. 13 indexed citations
8.
Umehara, Ken, Yoshihiko Shimokawa, & Gohachiro Miyamoto. (2002). Effect of Probucol on Cytochrome P450 Activities in Human Liver Microsomes.. Biological and Pharmaceutical Bulletin. 25(8). 1112–1114. 9 indexed citations
9.
Umehara, Ken, Shoji Kudo, Yukihiro Hirao, et al.. (2000). Oxidative Cleavage of the Octyl Side Chain of 1-(3,4-Dichlorobenzyl)-5-Octylbiguanide (OPB-2045) in Rat and Dog Liver Preparations. Drug Metabolism and Disposition. 28(8). 887–894. 9 indexed citations
10.
Umehara, Ken, et al.. (2000). Phenacetin Deacetylase Activity in Human Liver Microsomes: Distribution, Kinetics, and Chemical Inhibition and Stimulation. Journal of Pharmacology and Experimental Therapeutics. 294(1). 80–87. 22 indexed citations
11.
Fujio, N, Masayuki Furukawa, & Gohachiro Miyamoto. (2000). Distribution (Autoradiography) of a New Synthetic Antibacterial Agent OPB-2045 in Rats.. Drug Metabolism and Pharmacokinetics. 15(4). 309–317. 1 indexed citations
12.
Kudo, Shoji, Masayuki Furukawa, Hiroshi Okumura, et al.. (1998). Percutaneous Absorption and Tissue Distribution of 1-(3,4-dichlorobenzyl)-5-octylbiguanide (OPB-2045) in Rats.. Drug Metabolism and Pharmacokinetics. 13(1). 13–20. 1 indexed citations
13.
Kudo, Shoji, Ken Umehara, Masaaki Odomi, & Gohachiro Miyamoto. (1998). Metabolism of a New Bactericidal Antiseptic, OPB-2045, in Rats following Subcutaneous Administration.. Drug Metabolism and Pharmacokinetics. 13(4). 346–350. 5 indexed citations
14.
Umehara, Ken, et al.. (1998). Metabolism of 1-(3,4-dichlorobenzyl)-5- octylbiguanide in the dog. Xenobiotica. 28(5). 507–514. 6 indexed citations
15.
Miyamoto, Gohachiro, Nasir Zahid, & Jack Uetrecht. (1997). Oxidation of Diclofenac to Reactive Intermediates by Neutrophils, Myeloperoxidase, and Hypochlorous Acid. Chemical Research in Toxicology. 10(4). 414–419. 96 indexed citations
16.
Akiyama, Hitoshi, et al.. (1990). The distribution of OPC-7251 in the skin.. Drug Metabolism and Pharmacokinetics. 5(2). 199–208. 1 indexed citations
17.
18.
Akiyama, Hitoshi, et al.. (1983). High-performance liquid chromatographic procedure for the determination of probucol in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 277. 419–422. 16 indexed citations
19.
Miyamoto, Gohachiro, et al.. (1979). Pharmacokinetics of procaterol in the rat, rabbit and beagle dog.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 29(2). 266–70. 12 indexed citations
20.
Shimizu, Takae, et al.. (1978). The Metabolism of a Bronchodilator Procaterol HCl in the Ratin vitroandin vivo. Xenobiotica. 8(6). 349–358. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.‐M. POIRIER Breakdown of academic impact, for papers by Joan Moncrieff Breakdown of academic impact, for papers by Leon Shargel Breakdown of academic impact, for papers by W. Roth Breakdown of academic impact, for papers by V.G. Casabó Breakdown of academic impact, for papers by Rebecca L. Oberle Breakdown of academic impact, for papers by Barbara W. LeDuc Breakdown of academic impact, for papers by Michael A. Zemaitis Breakdown of academic impact, for papers by DB Jack Breakdown of academic impact, for papers by D. Tang–Liu
Rankless by CCL
2026